Week of January 17, 2023 | Vol. 12, Issue 2

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

[email protected]


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

[email protected]

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

SCOPE Summit for Clinical Ops Executives

February 6-9, 2023 - Orlando, FL

CPHA 2023

March 19-21, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A TRANSACTIONS

Pharma & Biotech

8 transactions totaling $4 billion


Supplies, Equipment & Services

26 transactions totaling $24 million


Healthcare Facilities & Distributors

16 transactions


Healthcare IT & Managed Care

7 transactions

PRIVATE PLACEMENTS

Pharma & Biotech

23 transactions totaling $362 million


Supplies, Equipment & Services

35 transactions totaling $361 million


Healthcare Facilities & Distributors

7 transactions totaling $25 million


Healthcare IT & Managed Care

27 transactions totaling $532 million

PUBLIC OFFERINGS

Pharma & Biotech

8 transactions totaling $234 million


Supplies, Equipment & Services

2 transactions totaling $26 million


Healthcare Facilities & Distributors

2 transactions


Healthcare IT & Managed Care

0 transactions

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider


Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

JPM23: Carbon Health nabs $100M, CVS Health partnership to pilot primary care in retail stores

Fierce Healthcare - Jan 9, 2023

AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline

AstraZeneca - Jan 9, 2023

Huma acquires Germany's Alcedis to expand its DCT offerings

Fierce Biotech - Jan 10, 2023

Pinnacle completes purchase of South Texas Research Institute with focus on NASH

Fierce Biotech - Jan 11, 2023

Valo Selects Exothera to Develop Large-scale Oncolytic Adenovirus Manufacturing

Contract Pharma - Jan 11, 2023

IMA snaps up Clinical Trials of America to extend southeast US footprint

Fierce Biotech - Jan 11, 2023

Theragent Enters Stem Cell Bank Production Contract with Accelerated Biosciences

Contract Pharma - Jan 13, 2023

Resilience to Build New Biopharma Manufacturing Facility in the UAE

Contract Pharma - Jan 13, 2023

Alora Pharmaceuticals Acquires Monarch Manufacturing Facility

Contract Pharma - Jan 13, 2023

TANNER NEWS

Linkedin  

Pharma Trends & Opportunities in Latin America

For pharma companies interested in product expansion, Latin America is one of the most dynamic regions in the world. Steve Scalia offers his perspective on the challenges and opportunities in emerging LATAM pharma markets. Read more.

Increasing the Efficiency of Clinical Trials

Tanner EVP Georg Schulz offers his perspective on the trends and challenges affecting clinical trials, including the growing prevalence of digital and decentralized trials and ongoing supply chain issues. Read more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.